Is it a must-win for Biogen over Forward Pharma?

Biogen has had a news-breaking start to the year, first with Michael Vounatsos taking over as the CEO of the company; and second, with Vounatsos announcing a payout of $1.25 billion to Forward Pharma to settle a patent licensing agreement. Vounatos has been quoted in the media as saying this will help strengthen Biogen’s intellectual property... (Featured image source: https://www.pexels.com/photo/dark-purple-black-medicine-119931/) *** Biogen has had a news-breaking start to the year, first Read more [...]
Dr. Nalini Mohan Koutha
Dr. Nalini Mohan Koutha

Dr. Nalini is a Pharmaceutical patent expert and has extensive experience as a technical and Intellectual Property Specialist in Generic Pharmaceutical manufacturing. His quest for analytical thinking extends to his deep interest in philately.


Post a Comment

Your email address will not be published. Required fields are marked *